224 related articles for article (PubMed ID: 20532841)
1. Current treatment strategy and new agents in mantle cell lymphoma.
Ogura M
Int J Hematol; 2010 Jul; 92(1):25-32. PubMed ID: 20532841
[TBL] [Abstract][Full Text] [Related]
2. [Current treatment strategy in mantle cell lymphoma].
Ogura M
Nihon Rinsho; 2014 Mar; 72(3):499-511. PubMed ID: 24724411
[TBL] [Abstract][Full Text] [Related]
3. Current treatment standards and emerging strategies in mantle cell lymphoma.
Dreyling M; Hiddemann W;
Hematology Am Soc Hematol Educ Program; 2009; ():542-51. PubMed ID: 20008239
[TBL] [Abstract][Full Text] [Related]
4. Update on the molecular pathogenesis and clinical treatment of Mantle Cell Lymphoma (MCL): minutes of the 9th European MCL Network conference.
Dreyling M; Hoster E; Bea S; Hartmann E; Horn H; Hutter G; Salaverria I; Pott C; Trneny M; Le Gouill S; Cortelazzo S; Szymczyk M; Jurczak W; Shpilberg O; Ribrag V; Hermine O;
Leuk Lymphoma; 2010 Sep; 51(9):1612-22. PubMed ID: 20629519
[TBL] [Abstract][Full Text] [Related]
5. Mantle cell lymphoma: state-of-the-art management and future perspective.
Weigert O; Unterhalt M; Hiddemann W; Dreyling M
Leuk Lymphoma; 2009 Dec; 50(12):1937-50. PubMed ID: 19863180
[TBL] [Abstract][Full Text] [Related]
6. Treatment options for mantle cell lymphoma.
Smolewski P; Witkowska M; Robak T
Expert Opin Pharmacother; 2015; 16(16):2497-507. PubMed ID: 26360791
[TBL] [Abstract][Full Text] [Related]
7. Mantle cell lymphoma-current literature overview.
Pejcic I; Petkovic I; Vrbic S; Filipovic S; Balic M; Cvetanovic A
J BUON; 2014; 19(2):342-9. PubMed ID: 24965390
[TBL] [Abstract][Full Text] [Related]
8. An update on the role of high-dose therapy with autologous or allogeneic stem cell transplantation in mantle cell lymphoma.
Jacobsen E; Freedman A
Curr Opin Oncol; 2004 Mar; 16(2):106-13. PubMed ID: 15075900
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies in mantle cell lymphoma.
Hanel W; Epperla N
J Hematol Oncol; 2020 Jun; 13(1):79. PubMed ID: 32552760
[TBL] [Abstract][Full Text] [Related]
10. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 10th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Kluin-Nelemans HC; Beà S; Hartmann E; Salaverria I; Hutter G; Perez-Galan P; Roue G; Pott C; Le Gouill S; Cortelazzo S; Rule S; Hess G; Zaja F; Vitolo U; Szymczyk M; Walewski J; Ribrag V; Unterhalt M; Hermine O; Hoster E;
Leuk Lymphoma; 2011 Dec; 52(12):2226-36. PubMed ID: 21851218
[TBL] [Abstract][Full Text] [Related]
11. [Mantle Cell Lymphoma - Cutting edge Dia-gnostics and Treatment Approaches].
Klener P; Trněný M
Klin Onkol; 2015; 28 Suppl 3():3S80-6. PubMed ID: 26489506
[TBL] [Abstract][Full Text] [Related]
12. Mantle cell lymphoma: 2015 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2015 Aug; 90(8):739-45. PubMed ID: 26103436
[TBL] [Abstract][Full Text] [Related]
13. Update on the molecular pathogenesis and clinical treatment of mantle cell lymphoma: report of the 11th annual conference of the European Mantle Cell Lymphoma Network.
Dreyling M; Kluin-Nelemans HC; Beà S; Klapper W; Vogt N; Delfau-Larue MH; Hutter G; Cheah C; Chiappella A; Cortelazzo S; Pott C; Hess G; Visco C; Vitolo U; Klener P; Aurer I; Unterhalt M; Ribrag V; Hoster E; Hermine O;
Leuk Lymphoma; 2013 Apr; 54(4):699-707. PubMed ID: 23020649
[TBL] [Abstract][Full Text] [Related]
14. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
15. [Current strategies in the treatment of advanced stage mantle cell lymphoma].
Lenz G; Dreyling M; Unterhalt M; Hiddemann W
Dtsch Med Wochenschr; 2004 Nov; 129(45):2429-33. PubMed ID: 15529247
[TBL] [Abstract][Full Text] [Related]
16. Management of relapsed mantle cell lymphoma: still a treatment challenge.
Ruan J; Coleman M; Leonard JP
Oncology (Williston Park); 2009 Jul; 23(8):683-90. PubMed ID: 19711582
[TBL] [Abstract][Full Text] [Related]
17. Should there be a standard therapy for mantle cell lymphoma?
Smith MR
Future Oncol; 2011 Feb; 7(2):227-37. PubMed ID: 21345142
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy with rituximab following high-dose therapy and autologous stem-cell transplantation for mantle cell lymphoma.
Mangel J; Buckstein R; Imrie K; Spaner D; Crump M; Tompkins K; Reis M; Perez-Ordonez B; Deodhare S; Romans R; Pennell N; Robinson JB; Hewitt K; Richardson P; Lima A; Pavlin P; Berinstein NL
Semin Oncol; 2002 Feb; 29(1 Suppl 2):56-69. PubMed ID: 11842390
[TBL] [Abstract][Full Text] [Related]
19. Dose-intense treatment of mantle cell lymphoma: can durable remission be achieved?
Dreyling M; Hiddemann W
Curr Opin Oncol; 2008 Sep; 20(5):487-94. PubMed ID: 19106649
[TBL] [Abstract][Full Text] [Related]
20. Mantle cell lymphoma: 2012 update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2012 Jun; 87(6):604-9. PubMed ID: 22615102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]